What we published in December 2024

Books on shelves
  1. Alexander JL, Caldera F. Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Aliment Pharmacol Ther. 2025;61(2):380-381.
  2. Alexander JL, Powell N, Caldera F, Kennedy N, Din S. Widening access to recombinant zoster vaccination in IBD. Lancet Gastroenterol Hepatol. 2024.
  3. Argiris G, Akinci M, Peña-Gómez C, Palpatzis E, Garcia-Prat M, Shekari M, Blennow K, Zetterberg H, Kollmorgen G, Quijano-Rubio C, Ashton NJ, Karikari TK, Brinkmalm-Westman A, Lantero-Rodriguez J, Fauria K, Sánchez-Benavides G, Grau-Rivera O, Suárez-Calvet M, Arenaza-Urquijo EM, Study FTA. Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease. Alzheimers Res Ther. 2024;16(1):274.
  4. Bentivenga GM, Gonzalez-Ortiz F, Baiardi S, Kirsebom BE, Mastrangelo A, Mammana A, Capellari S, Fladby T, Zetterberg H, Blennow K, Parchi P. Clinical value of novel blood-based tau biomarkers in Creutzfeldt-Jakob disease. Alzheimers Dement. 2024.
  5. Bergström S, Mravinacová S, Lindberg O, Zettergren A, Westman E, Wahlund LO, Blennow K, Zetterberg H, Kern S, Skoog I, Månberg A. CSF levels of brain-derived proteins correlate with brain ventricular volume in cognitively healthy 70-year-olds. Clin Proteomics. 2024;21(1):65.
  6. Berkowitz L, Razquin C, Salazar C, Biancardi F, Estruch R, Ros E, Fitó M, Corella D, Coe CL, Ryff CD, Ruiz-Canela M, Salas-Salvado J, Wang D, Hu FB, Deik A, Martínez-Gonzalez MA, Rigotti A. Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies. Cardiovasc Diabetol. 2024;23(1):446.
  7. Biesterveld BE, Mandelbrot D, Huang W, Garonzik-Wang J. Oxalate nephropathy after kidney transplantation: A common cause of graft dysfunction, but uncommon cause of ureter stricture. Am J Transplant. 2025;25(1):215-218.
  8. Bluma M, Chiotis K, Bucci M, Savitcheva I, Matton A, Kivipelto M, Jeromin A, De Santis G, Di Molfetta G, Ashton NJ, Blennow K, Zetterberg H, Nordberg A. Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics. EBioMedicine. 2024:105504.
  9. Böken D, Xia Z, Lam JYL, Fertan E, Wu Y, English EA, Konc J, Layburn F, Bernardes GJL, Zetterberg H, Cheetham MR, Klenerman D. Ultrasensitive Protein Aggregate Quantification Assays for Neurodegenerative Diseases on the Simoa Platform. Anal Chem. 2024.
  10. Bolton CJ, Steinbach M, Khan OA, Liu D, O'Malley J, Dumitrescu L, Peterson A, Jefferson AL, Hohman TJ, Zetterberg H, Gifford KA. Clinical and demographic factors modify the association between plasma phosphorylated tau-181 and cognition. Alzheimers Dement (Amst). 2024;16(4):e70047.
  11. Brasier AR. Interactions between epithelial mesenchymal plasticity, barrier dysfunction and innate immune pathways shape the genesis of allergic airway disease. Expert Rev Respir Med. 2025:1-13.
  12. Bratseth V, Watne LO, Neerland BE, Halaas NB, Pollmann CT, Karabeg A, Odegaard OT, Sydnes K, Zetterberg H, Seljeflot I, Helseth R. Increased cell-free DNA in CSF and serum of hip fracture patients with delirium. Brain Commun. 2025;7(1):fcae452.
  13. Bruce JY, Burr A, Kimple RJ, Adam DP, Yu M, Piaskowski SM, Glazer TA, Hill P, Hartig GK, McCulloch TM, Wieland AM, Trask D, Oliver K, Longcor J, Rogus-Pulia N, Cho SY, Bednarz B, Harari PM. Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study. EBioMedicine. 2024;111:105496.
  14. Burden M, Keniston A, McBeth L, Astik G, Kangelaris KN, Kochar A, Knees M, Segon A, Westergaard S, Yu A, Sakumoto M, Chadha R. Big brother or big opportunity? Utilization of EHR use metadata in the inpatient setting: A mixed methods study at 16 organizations. J Hosp Med. 2024.
  15. Cacciaglia R, Shekari M, Salvadó G, Milà-Alomà M, Falcon C, Sánchez-Benavides G, Minguillón C, Fauria K, Grau-Rivera O, Molinuevo JL, Blennow K, Zetterberg H, Quevenco FC, Suárez-Calvet M, Gispert JD. The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease. Brain Commun. 2025;7(1):fcae451.
  16. Callister C, Astik G, Atkins RM, Alday A, Dayton K, Keniston A, Linker A, McBeth L, Merriman J, Westergaard S, Yu A, Auerbach A, Burden M. Optimizing learners on direct care teaching services: A qualitative study of hospitalist clinicians at 26 sites. J Hosp Med. 2024.
  17. Capogna E, Sørensen Ø, Watne LO, Roe J, Strømstad M, Idland AV, Halaas NB, Blennow K, Zetterberg H, Walhovd KB, Fjell AM, Vidal-Piñeiro D. Subtypes of brain change in aging and their associations with cognition and Alzheimer's disease biomarkers. Neurobiol Aging. 2024;147:124-140.
  18. Clarin M, Hellberg A, Blennow K, Andreasson U, Zetterberg H. Stability of bilirubin and oxyhaemoglobin in cerebrospinal fluid. Scand J Clin Lab Invest. 2024:1-5.
  19. Coulis A, Levanon S, Randhawa G, Brailovsky Y, Raza F, Oliveros E. Cardiopulmonary exercise testing in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Front Sports Act Living. 2024;6:1477562.
  20. Deming DA. Development of KRAS Inhibitors and Their Role for Metastatic Colorectal Cancer. J Natl Compr Canc Netw. 2025:1-5.
  21. Eberlein M, Johnson CA, Guzy R, Lowery E, McCarthy DP. Right- versus left-first implantation in off-pump sequential double-lung transplantation: physiology and size matter? Eur J Cardiothorac Surg. 2024;66(6).
  22. Eix EF, Nett JE. Candida auris: Epidemiology and Antifungal Strategy. Annu Rev Med. 2024.
  23. Esnault S, Bernau K, Floerke HL, Dendooven A, Delaunay E, Dill-McFarland KA, Altman MC, Busse WW, Rosenkranz MA, Tattersall MC, Johansson MW, Labreuche J, Beury D, Sebda S, Dezoteux F, Segard B, Mortuaire G, Staumont-Sallé D, Stoup T, Chenivesse C, Sandbo N, Jarjour NN, Lefèvre G. Oncostatin-M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe Asthma. Allergy. 2024.
  24. Fritz ML, Sommovilla J, Lawson EH, Zelenski AB, Schwarze ML, De Roo AC. "So, what are you saying?": A qualitative study of surgeon-patient communication in the rectal cancer consultations. Am J Surg. 2024;240:116115.
  25. Garg S, Astor BC, Lim SS, Raval AN, Zhong W, Panzer SE, Khosroshahi A, Rovin B, Bartels CM. Renal Arteriosclerosis in kidney biopsies associated with higher 10-year atherosclerotic cardiovascular disease in lupus nephritis. Rheumatology (Oxford). 2024.
  26. Geiger G, Revette A, Nava-Coulter B, Kiel L, Kaufman R, Morabito A, Horiguchi M, Martinez-Aceves C, Meza K, Fakorede O, Christophers B, Orellana P, Pinzon MM, Lubner SJ, Florez N. Understanding the experience of Latinas in medical education: A qualitative study. Cancer. 2025;131(1):e35700.
  27. Gibson LL, Gonzalez MC, Ashton NJ, Tovar-Rios D, Blanc F, Pilotto A, Lemstra A, Paquet C, Ballard C, Zetterberg H, Aarsland D. Plasma phosphorylated tau and neuropsychiatric symptoms in dementia with Lewy bodies. Alzheimers Dement. 2024.
  28. Gonzalez-Ortiz F, Holmegaard L, Andersson B, Brännmark C, Blomstrand C, Zetterberg H, Jood K, Blennow K, Jern C, Stanne TM. Plasma brain-derived tau correlates with cerebral infarct volume. J Intern Med. 2024.
  29. Goyal L, DiToro D, Facchinetti F, Martin EE, Peng P, Baiev I, Iyer R, Maurer J, Reyes S, Zhang K, Majeed U, Berchuck JE, Chen CT, Walmsley C, Pinto C, Vasseur D, Gordan JD, Mody K, Borad M, Karasic T, Damjanov N, Danysh BP, Wehrenberg-Klee E, Kambadakone AR, Saha SK, Hoffman ID, Nelson KJ, Iyer S, Qiang X, Sun C, Wang H, Li L, Javle M, Lin B, Harris W, Zhu AX, Cleary JM, Flaherty KT, Harris T, Shroff RT, Leshchiner I, Parida L, Kelley RK, Fan J, Stone JR, Uboha NV, Hirai H, Sootome H, Wu F, Bensen DC, Hollebecque A, Friboulet L, Lennerz JK, Getz G, Juric D. A Model for Decoding Resistance in Precision Oncology: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma. Ann Oncol. 2024.
  30. Hashimoto T, Putman RK, Massaro AF, Shiozawa Y, McGough K, McCabe KK, Linden JA, Wang W, Liu SW, Kennedy M, Neville TH, Kruser JM, Sudore RL, Schonberg MA, Tulsky JA, Ouchi K. Study protocol for a randomized controlled trial: Integrating the 'Time-limited Trial' in the emergency department. PLoS One. 2024;19(12):e0313858.
  31. Hewitt A, Freeman MJ, Leverson G, Bailey HH, Carchman E, Striker R, Sanger CB. National Analysis of Over 48,000 Veterans With HIV Demonstrates CD4/CD8 Ratio as a Risk Marker for Anal Intraepithelial Lesions and Anal Cancer. Dis Colon Rectum. 2025.
  32. Holtan SG, Bolaños-Meade J, Al Malki MM, Wu J, Kitko CL, Reshef R, Rezvani AR, Shaffer BC, Solh MM, Yao JM, Runaas L, Elmariah H, Larkin KT, El Jurdi N, Gooptu M, Loren AW, Hall AC, Alousi AM, Jamy O, Clark W, Kean L, Bhatt AS, Perales MA, Applegate K, Efebera YA, Leifer E, Jones RJ, Horowitz MM, Mattila D, Saber W, Hamadani M, Martens MJ. Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703. J Clin Oncol. 2025:Jco2400921.
  33. Huang Q, Bolt D, Jonaitis E, Hermann B, Studer R, Du L, Ryther B, Sparks L, Galvin JE, Johnson S, Langhough R. Performance of study partner reports in a non-demented at-risk sample. Alzheimers Dement. 2024.
  34. Hung J, Vonasek B, Rosenberg D, Vo T, Striker R. Using T-Cell Subsets to Better Characterize Immunoresiliency and Immunodeficiency in Patients with Recurrent Infections. Infect Dis Rep. 2024;16(6):1230-1239.
  35. Jawara D, Lauer KV, Venkatesh M, Stalter LN, Hanlon B, Churpek MM, Funk LM. Using Machine Learning to Predict Weight Gain in Adults: an Observational Analysis From the All of Us Research Program. J Surg Res. 2024;306:43-53.
  36. Jindal T, Jiang C, Alhalabi O, Nizam A, Nguyen C, Talukder R, Bakaloudi D, Davidsohn M, Freeman D, Glover M, Khaki AR, Evans S, Lemke E, Bose R, Sim W, Pywell C, Basu A, Kilari D, Barata PC, Bilen MA, Zakharia Y, Milowsky MI, Shah SA, Bellmunt J, Grivas P, Emamekhoo H, Davis NB, Gupta S, Hoimes C, Campbell MT, Alva A, Koshkin VS. Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data. Eur Urol Oncol. 2024.
  37. Kaiksow FA. Diagnostic delay: lessons learnt from marginalised voices. BMJ Qual Saf. 2024.
  38. Kaiksow FA, Brendel M, Hubbard CC, Lee T, Chia D, Brooks K, Ruhnke GW, Raffel KE, Goyal A, Kantor MA, Helminski AS, Alday A, Astik GJ, Barish P, Schnipper JL, Auerbach AD. Measuring the association between diagnostic errors and neighborhood disadvantage. J Hosp Med. 2024.
  39. Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Kendell-Thomas J, Kapoor E, Faubion LL, Schwarz CG, Senjem ML, Fields JA, Min PH, Lowe VJ, Jack CR, Jr., Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy. Menopause. 2025;32(1):12-22.
  40. Keating C, Yonker LM, Vermeulen F, Prais D, Linnemann RW, Trimble A, Kotsimbos T, Mermis J, Braun AT, O'Carroll M, Sutharsan S, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Floreth T, Michelson P, Sosnay PR, Nair N, Zahigian R, Martin H, Ahluwalia N, Lam A, Horsley A. Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials. Lancet Respir Med. 2024.
  41. Kurtz J, Maloney C, Eastman T, Lowery E. Successful Medical Management of Pulmonary Gangrene in a Transplanted Lung. Transplant Proc. 2024;56(9):2092-2095.
  42. Kužma M, Vaňuga P, Pávai D, Killinger Z, Hans D, Binkley N, Payer J, Jackuliak P. Association of trabecular bone score corrected for tissue thickness with glucose metabolism in acromegaly. Front Endocrinol (Lausanne). 2024;15:1448566.
  43. Le Borgne J, Gomez L, Heikkinen S, Amin N, Ahmad S, Choi SH, Bis J, Grenier-Boley B, Rodriguez OG, Kleineidam L, Young J, Tripathi KP, Wang L, Varma A, Campos-Martin R, van der Lee S, Damotte V, de Rojas I, Palmal S, Lipton R, Reiman E, McKee A, De Jager P, Bush W, Small S, Levey A, Saykin A, Foroud T, Albert M, Hyman B, Petersen R, Younkin S, Sano M, Wisniewski T, Vassar R, Schneider J, Henderson V, Roberson E, DeCarli C, LaFerla F, Brewer J, Swerdlow R, Van Eldik L, Hamilton-Nelson K, Paulson H, Naj A, Lopez O, Chui H, Crane P, Grabowski T, Kukull W, Asthana S, Craft S, Strittmatter S, Cruchaga C, Leverenz J, Goate A, Kamboh MI, George-Hyslop PS, Valladares O, Kuzma A, Cantwell L, Riemenschneider M, Morris J, Slifer S, Dalmasso C, Castillo A, Küçükali F, Peters O, Schneider A, Dichgans M, Rujescu D, Scherbaum N, Deckert J, Riedel-Heller S, Hausner L, Molina-Porcel L, Düzel E, Grimmer T, Wiltfang J, Heilmann-Heimbach S, Moebus S, Tegos T, Scarmeas N, Dols-Icardo O, Moreno F, Pérez-Tur J, Bullido MJ, Pastor P, Sánchez-Valle R, Álvarez V, Boada M, García-González P, Puerta R, Mir P, Real LM, Piñol-Ripoll G, García-Alberca JM, Royo JL, Rodriguez-Rodriguez E, Soininen H, de Mendonça A, Mehrabian S, Traykov L, Hort J, Vyhnalek M, Thomassen JQ, Pijnenburg YAL, Holstege H, van Swieten J, Ramakers I, Verhey F, Scheltens P, Graff C, Papenberg G, Giedraitis V, Boland A, Deleuze JF, Nicolas G, Dufouil C, Pasquier F, Hanon O, Debette S, Grünblatt E, Popp J, Ghidoni R, Galimberti D, Arosio B, Mecocci P, Solfrizzi V, Parnetti L, Squassina A, Tremolizzo L, Borroni B, Nacmias B, Spallazzi M, Seripa D, Rainero I, Daniele A, Bossù P, Masullo C, Rossi G, Jessen F, Fernandez V, Kehoe PG, Frikke-Schmidt R, Tsolaki M, Sánchez-Juan P, Sleegers K, Ingelsson M, Haines J, Farrer L, Mayeux R, Wang LS, Sims R, DeStefano A, Schellenberg GD, Seshadri S, Amouyel P, Williams J, van der Flier W, Ramirez A, Pericak-Vance M, Andreassen OA, Van Duijn C, Hiltunen M, Ruiz A, Dupuis J, Martin E, Lambert JC, Kunkle B, Bellenguez C. X-chromosome-wide association study for Alzheimer's disease. Mol Psychiatry. 2024.
  44. Lee I, Ganesan A, Kalesinskas L, Zheng H, Ahn HC, Christenson S, Erzurum SC, Zein J, Bleecker ER, Meyers DA, Castro M, Fahy JV, Israel E, Jarjour NN, Moore W, Wenzel SE, Mauger DT, Levy BD, Woodruff PG, Ortega VE, Khatri P. Multicohort Analysis of Bronchial Epithelial Cell Expression in Healthy Subjects and Patients with Asthma Reveals Four Clinically Distinct Clusters. Am J Respir Cell Mol Biol. 2024.
  45. Leite de Campos J, Kates A, Steinberger A, Sethi A, Suen G, Shutske J, Safdar N, Goldberg T, Ruegg PL. Variation in partial direct costs of dry cow therapy on 37 large dairy herds. JDS Commun. 2024;5(6):639-643.
  46. Li W, Li J, Wei C, Laviv T, Dong M, Lin J, Calubag M, Colgan LA, Jin K, Zhou B, Shen Y, Li H, Cui Y, Gao Z, Li T, Hu H, Yasuda R, Ma H. Boosting neuronal activity-driven mitochondrial DNA transcription improves cognition in aged mice. Science. 2024;386(6728):eadp6547.
  47. LoCastro M, Baran A, Liesveld J, Huselton E, Hill E, Loh KP, Mendler JH. Portable Medical Orders and Inpatient Cost at End of Life in Acute Myeloid Leukemia and Myelodysplastic Syndromes. JCO Oncol Pract. 2024:Op2400556.
  48. Lucey MR. Video introduction: Special issue on alcohol use disorder and liver disease. Hepatology. 2024;80(6):E93.
  49. Madrid A, Papale LA, Bergmann PE, Breen C, Clark LR, Asthana S, Johnson SC, Keleş S, Hogan KJ, Alisch RS. Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer's disease identifies cognitive status. Alzheimers Dement. 2025.
  50. Markowski MC, Ren Y, Tierney M, Royce TJ, Yamashita R, Croucher D, Huang HC, Todorovic T, Chen E, Showalter TN, Carducci MA, Chen YH, Liu G, Parker CTA, Esteva A, Feng FY, Attard G, Sweeney CJ. Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer. Eur Urol Oncol. 2024.
  51. McGregor ER, Lasky DJ, Rippentrop OJ, Clark JP, Wright S, Jones MV, Anderson RM. Reversal of neuronal tau pathology via adiponectin receptor activation. Commun Biol. 2025;8(1):8.
  52. McKay RR, Lang J, Beltran H. Clinical Implementation of Minimal Residual Disease Testing in Genitourinary Cancers: Bridging Promise and Practice. Eur Urol. 2024.
  53. Mehta SS, Surapaneni AL, Pandit K, Xu Y, Horwitz L, Blecker S, Blum MF, Chang AR, Shin JI, Grams ME. Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Prescriptions in Type 2 Diabetes by Kidney and Cardiovascular Disease. J Am Soc Nephrol. 2024.
  54. Mi RZ, Yang EF, Tahk A, Tarfa A, Cotter LM, Lu L, Yang S, Gustafson DH, Sr., Westergaard R, Shah D. mHealth Engagement for Antiretroviral Medication Adherence Among People With HIV and Substance Use Disorders: Observational Study. J Med Internet Res. 2024;26:e57774.
  55. Miller JR, Feng C, Ranum J, Striker R. Viruses tipping the scales: The role of the CD4/CD8 ratio in determining viral outcome. Virology. 2024;603:110333.
  56. Mora Pinzon M, Hills O, Levy G, James TT, Benitez A, Lawrence S, Ellis T, Washington V, Solorzano L, Tellez-Giron P, Cano Ospina F, Metoxen MF, Gleason CE. Implementation of a Social Media Strategy for Public Health Promotion in Black, American Indian or Alaska Native, and Hispanic or Latino Communities During the COVID-19 Pandemic: Cross-Sectional Study. J Med Internet Res. 2024;26:e58581.
  57. Mroz S, Daenen F, Dierickx S, Mortier F, De Panfilis L, Downar J, Lapenskie J, Anderson K, Skold A, Campbell C, Campbell TC, Feeney R, Willmott L, White BP, Chambaere K, Deliens L. Associations between physicians' personal preferences for end-of-life decisions and their own clinical practice: PROPEL survey study in Europe, North America, and Australia. Palliat Med. 2024:2692163241300853.
  58. Murphy CC, Patel SG, Liang PS, Weiss JM. Editorial: Disparities in early onset colorectal cancer. Front Oncol. 2024;14:1537473.
  59. Myers S, Miller TA, Gao Y, Churpek MM, Mayampurath A, Dligach D, Afshar M. Lessons learned on information retrieval in electronic health records: a comparison of embedding models and pooling strategies. J Am Med Inform Assoc. 2024.
  60. Ng TKS, Udeh-Momoh C, Lim MA, Gleerup HS, Leifert W, Ajalo C, Ashton N, Zetterberg H, Rissman RA, Winston CN, S OB, Jenkins R, Carro E, Orive G, Tamburin S, Olvera-Rojas M, Solis-Urra P, Esteban-Cornejo I, Santos G, Rajan KB, Koh D, Simonsen AH, Slowey PD. Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working Group. Alzheimers Dement. 2024.
  61. Okonkwo OC, Rivera-Mindt M, Weiner MW. Alzheimer's Disease Neuroimaging Initiative: Two decades of pioneering Alzheimer's disease research and future directions. Alzheimers Dement. 2025.
  62. Ollinger TL, Zarnowski R, Parker JE, Kelly SL, Andes DR, Stamnes MA, Krysan DJ. Genetic interaction analysis of Candida glabrata transcription factors CST6 and UPC2A in the regulation of respiration and fluconazole susceptibility. Antimicrob Agents Chemother. 2024:e0129424.
  63. Pearson AG, Miller KB, Corkery AT, Loggie NA, Howery AJ, Rivera-Rivera LA, Wieben O, Johnson KM, Johnson SC, Barnes JN. Lower neurovascular coupling response despite higher cerebral blood flow at rest in apolipoprotein ɛ4 positive adults. PLoS One. 2024;19(12):e0314744.
  64. Perellón-Alfonso R, Abellaneda-Pérez K, Pileckyte I, Cabello-Toscano M, Mulet-Pons L, Vaqué-Alcázar L, Cattaneo G, Redondo-Camós M, España-Irla G, Delgado-Gallen S, Sánchez JS, Zetterberg H, Tormos JM, Franzmeier N, Pascual-Leone A, Bartrés-Faz D. Spontaneous and perturbation-based EEG cortical excitability markers are associated with plasma p-tau181 concentration in healthy middle-aged adults. Heliyon. 2024;10(24):e41118.
  65. Perri G, French C, Agostinis-Sobrinho C, Anand A, Antarianto RD, Arai Y, Baur JA, Cauli O, Clivaz-Duc M, Colloca G, Demetriades C, de Lucia C, Di Gessa G, Diniz BS, Dotchin CL, Eaglestone G, Elliott BT, Espeland MA, Ferrucci L, Fisher J, Grammatopoulos DK, Hardiany NS, Hassan-Smith Z, Hastings WJ, Jain S, Joshi PK, Katsila T, Kemp GJ, Khaiyat OA, Lamming DW, Gallegos JL, Madeo F, Maier AB, Martin-Ruiz C, Martins IJ, Mathers JC, Mattin LR, Merchant RA, Moskalev A, Neytchev O, Ni Lochlainn M, Owen CM, Phillips SM, Pratt J, Prokopidis K, Rattray NJW, Rúa-Alonso M, Schomburg L, Scott D, Shyam S, Sillanpää E, Tan MMC, Teh R, Tobin SW, Vila-Chã CJ, Vorluni L, Weber D, Welch A, Wilson D, Wilson T, Zhao T, Philippou E, Korolchuk VI, Shannon OM. An expert consensus statement on biomarkers of ageing for use in intervention studies. J Gerontol A Biol Sci Med Sci. 2024.
  66. Peterson A, Sathe A, Zaras D, Yang Y, Durant A, Deters KD, Shashikumar N, Pechman KR, Kim ME, Gao C, Mohd Khairi N, Li Z, Yao T, Huo Y, Dumitrescu L, Gifford KA, Wilson JE, Cambronero FE, Risacher SL, Beason-Held LL, An Y, Arfanakis K, Erus G, Davatzikos C, Tosun D, Toga AW, Thompson PM, Mormino EC, Habes M, Wang D, Zhang P, Schilling K, Albert M, Kukull W, Biber SA, Landman BA, Johnson SC, Schneider J, Barnes LL, Bennett DA, Jefferson AL, Resnick SM, Saykin AJ, Hohman TJ, Archer DB. Sex and APOE ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer's disease. Alzheimers Dement. 2024.
  67. Piasecki TM, Korcarz CE, Hansen KM, Bolt DM, Fiore MC, Stein JH, Baker TB. Validity of the E-Cigarette Wisconsin Inventory of Smoking Dependence Motives (e-WISDM) in Exclusive E-Cigarette Users: Evidence from a Laboratory Self-Administration Study. Nicotine Tob Res. 2024.
  68. Pilotto A, Quaresima V, Trasciatti C, Tolassi C, Bertoli D, Mordenti C, Galli A, Rizzardi A, Caratozzolo S, Zancanaro A, Contador J, Hansson O, Palmqvist S, De Santis G, Zetterberg H, Blennow K, Brugnoni D, Suárez-Calvet M, Ashton NJ, Padovani A. Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison. Brain. 2024.
  69. Price SN, Lee JW, Gareen IF, Kircher SM, Kumar SK, Mayer IA, Saba NF, Fenske TS, Atkins MB, Hodi FS, Kyriakopoulos CE, Tempany-Afdhal CM, Shanafelt TD, Park ER, Wagner LI. Cigarette smoking and symptom burden: baseline results from 9 ECOG-ACRIN cancer clinical trials. J Pain Symptom Manage. 2024.
  70. Purtell CS, Wright JM. Atrial fibrillation ablation: The key ingredient for managing arrhythmia-induced cardiomyopathy. HeartRhythm Case Rep. 2024;10(11):773-774.
  71. Quispialaya KM, Therriault J, Aliaga A, Benedet AL, Ashton NJ, Karikari T, Cassa Macedo A, Rahmouni N, Tissot C, Fernandez Arias J, Wang YT, Trudel L, Hosseini SA, Matsudaira T, Chan T, Pascoal T, Gilfix B, Vitali P, Zimmer ER, Provost K, Soucy JP, Gauthier S, Zetterberg H, Jean-Claude BJ, Blennow K, Rosa-Neto P. Comparison of Plasma p-tau217 and [(18)F]FDG-PET for Identifying Alzheimer Disease in People With Early-Onset or Atypical Dementia. Neurology. 2025;104(2):e210211.
  72. Reader BF, Rosas L, Knopf BA, Liu Y, Alzate-Correa D, Bhat A, Carey A, Cuervo AM, Dayal S, Demarco RS, Elliehausen CJ, Englund DA, Hamilton HL, Johnston M, Kang P, Konopka AR, Lepola N, Presley CJ, Schafer MJ, Serrano J, Singer BD, Song MA, Stanford KI, Taylor J, Wei W, Yeh CY, Zhang L, Anderson RM, Bai H, Robbins PD, Lamming DW, Mihaylova MM, Rojas M, Mora AL. The Fifth Annual Symposium of the Midwest Aging Consortium. J Gerontol A Biol Sci Med Sci. 2024.
  73. Rhoads T, Wong CG, Cobos K, O'Bryant SE, Kind AJH, Miller JB. Differential associations of neighborhood disadvantage, race/ethnicity, and cognitive status with experiences of psychosocial distress in the HABS-HD cohort. Alzheimers Dement. 2024.
  74. Rosenstein I, Novakova L, Kvartsberg H, Nordin A, Rasch S, Rembeza E, Sandgren S, Malmeström C, Fruhwürth S, Axelsson M, Blennow K, Zetterberg H, Lycke J. Tyro3 and Gas6 are associated with white matter and myelin integrity in multiple sclerosis. J Neuroinflammation. 2024;21(1):320.
  75. Rowland HA, Miller G, Liu Q, Li S, Sharp NR, Ng B, Wei T, Arunasalam K, Koychev I, Hedegaard A, Ribe EM, Chan D, Chessell T, Kocagoncu E, Lawson J, Malhotra P, Ridha BH, Rowe JB, Thomas AJ, Zamboni G, Zetterberg H, Cader MZ, Wade-Martins R, Lovestone S, Nevado-Holgado A, Kormilitzin A, Buckley NJ. Changes in iPSC-Astrocyte morphology reflect Alzheimer's disease patient clinical markers. Stem Cells. 2024.
  76. Shields RK, Abbo LM, Ackley R, Aitken SL, Albrecht B, Babiker A, Burgoon R, Cifuentes R, Claeys KC, Curry BN, DeSear KE, Gallagher JC, Golnabi EY, Gross AE, Hand J, Heil EL, Hornback KM, Kaye KS, Khuu TV, Klatt ME, Kline EG, Kubat RC, Kufel WD, Lee JH, Lepak AJ, Lim A, Ludwig JM, Macdougall C, Majumdar A, Mathers AJ, McCreary EK, Miller WR, Monogue ML, Moore WJ, Olson S, Oxer J, Pearson JC, Pham C, Pinargote P, Polk C, Satlin MJ, Satola SW, Shah S, Tamma PD, Tran TT, van Duin D, VanNatta M, Vega A, Venugopalan V, Veve MP, Wangchinda W, Witt LS, Wu JY, Pogue JM. Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study. Lancet Infect Dis. 2024.
  77. Shiyanbola OO, Maurer MA, Piper ME, Bolt D, Sharp LK, Ouayogodé MH, Fisher E. Optimizing diabetes management interventions for Black and Hispanic adults using the multiphase optimization strategy: Protocol for a randomized mixed methods factorial trial. Contemp Clin Trials. 2025:107804.
  78. Solomon D, Moon J, Parmasad V, Hernandez S, Wiegmann D, Safdar N. Examining the implementation of a multi-site evidence-based intervention to reduce fluoroquinolone usage: A qualitative content analysis of staff interviews to identify facilitators and barriers. Appl Ergon. 2024;125:104419.
  79. Spicer AB, Churpek MM. Can Machine Learning Raise Early Goal-Directed Therapy From the Grave? Crit Care Med. 2024.
  80. Tang C, Eisenmenger LB, Rivera-Rivera L, Huo E, Junn JC, Kuner AD, Oechtering TH, Peret A, Starekova J, Johnson KM. Incorporating Radiologist Knowledge Into MRI Quality Metrics for Machine Learning Using Rank-Based Ratings. J Magn Reson Imaging. 2024.
  81. Teunissen CE, Kolster R, Triana-Baltzer G, Janelidze S, Zetterberg H, Kolb HC. Plasma p-tau immunoassays in clinical research for Alzheimer's disease. Alzheimers Dement. 2024.
  82. Thornton J, Giuffre A, Donohue S, Hollnagel F, Tischendorf J. Skin Color Representation in Infectious Disease Textbooks. Open Forum Infect Dis. 2024;11(12):ofae703.
  83. Trautner B, Schweizer ML. Low-quality evidence on practices to prevent transmission of resistant organisms calls for rigorous trials and a paradigm shift. BMJ Qual Saf. 2024.
  84. Uboha NV, Basree MM, Eickhoff JC, Deming DA, Matkowskyj K, Maloney J, McCarthy D, DeCamp M, LoConte N, Emmerich PB, Kraus S, Patel MA, Kratz JD, Lubner SJ, Hurst N, Bassetti MF. Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer. J Surg Oncol. 2025.
  85. Van Egroo M, Beckers E, Ashton NJ, Blennow K, Zetterberg H, Jacobs HIL. Sex differences in the relationships between 24-h rest-activity patterns and plasma markers of Alzheimer's disease pathology. Alzheimers Res Ther. 2024;16(1):277.
  86. Vrtikapa D, Krasowski AA, Orland KM, Eckhardt LL. Dynamic role of hormones on Brugada syndrome phenotype. HeartRhythm Case Rep. 2024;10(11):843-846.
  87. Weiner MW, Kanoria S, Miller MJ, Aisen PS, Beckett LA, Conti C, Diaz A, Flenniken D, Green RC, Harvey DJ, Jack CR, Jr., Jagust W, Lee EB, Morris JC, Nho K, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Veitch DP. Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials. Alzheimers Dement. 2024.
  88. Weinrieb R, Medda R, Lucey MR. Therapy of alcohol use disorder in liver transplant recipients. Liver Transpl. 2024.
  89. Weng LC, Rämö JT, Jurgens SJ, Khurshid S, Chaffin M, Hall AW, Morrill VN, Wang X, Nauffal V, Sun YV, Beer D, Lee S, Nadkarni GN, Duong T, Wang B, Czuba T, Austin TR, Yoneda ZT, Friedman DJ, Clayton A, Hyman MC, Judy RL, Skanes AC, Orland KM, Treu TM, Oetjens MT, Alonso A, Soliman EZ, Lin H, Lunetta KL, van der Pals J, Issa TZ, Nafissi NA, May HT, Leong-Sit P, Roselli C, Choi SH, Khan HR, Knight S, Karlsson Linnér R, Bezzina CR, Ripatti S, Heckbert SR, Gaziano JM, Loos RJF, Psaty BM, Smith JG, Benjamin EJ, Arking DE, Rader DJ, Shah SH, Roden DM, Damrauer SM, Eckhardt LL, Roberts JD, Cutler MJ, Shoemaker MB, Haggerty CM, Cho K, Palotie A, Wilson PWF, Ellinor PT, Lubitz SA. The impact of common and rare genetic variants on bradyarrhythmia development. Nat Genet. 2025.
  90. Winfree RL, Nolan E, Blennow K, Zetterberg H, Gifford KA, Pechman KR, Schneider J, Bennett DA, Petyuk VA, Jefferson AL, Hohman TJ. Vascular endothelial growth factor receptor-1 (FLT1) interactions with amyloid-beta in Alzheimer's disease: A putative biomarker of amyloid-induced vascular damage. Neurobiol Aging. 2024;147:141-149.
  91. Xu S, Zhu Z, Gu TJ, Wang Z, Delafield DG, Rigby MJ, Lu G, Ma M, Liu PK, Puglielli L, Li L. sn-Position-Resolved Quantification of Aminophospholipids by Isotopic N,N-Dimethyl Leucine Labeling and High-Resolution Ion Mobility Mass Spectrometry. Anal Chem. 2024;96(50):20098-20106.
  92. Yamamoto S, Horita N, Imai R, Niitsu T. Surgical and Bronchoscopic Lung Volume Reduction for Severe Emphysema: A Systematic Review and Network Meta-analysis. Lung. 2025;203(1):22.
  93. Yang KL, Kelble L, Felten K, Carlsson CM, Clark LR. Memory screening in the community: Facilitating earlier dementia diagnosis and care-Preliminary data. J Am Geriatr Soc. 2024.
  94. Yao Y, Astor BC, Yang W, Greene T, Li L. Predicting kidney graft function and failure among kidney transplant recipients. BMC Med Res Methodol. 2024;24(1):324.
  95. Zinsli KA, Bhatraju EP, Feinberg J, Stopka TJ, Friedmann PD, Zule W, Cooper HLF, Young AM, Korthuis PT, Pho MT, Jenkins WD, Miller WC, Go VF, Seal DW, Westergaard RP, Fredericksen RJ, Delaney JA, Tsui JI. Buprenorphine Injection Among Rural Persons Who Inject Drugs. JAMA Netw Open. 2024;7(12):e2450108.
  96. Þorgeirsdóttir B, Sievert T, Lybeck A, Ashton NJ, Blennow K, Zetterberg H, Friberg H, Frigyesi A. Plasma phosphorylated tau (p-tau231) and total tau (t-tau) as prognostic markers of neurological outcome after cardiac arrest - a multicentre study. Resuscitation. 2024:110450.